Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
Whitepaper

Study: Comparing Efficacy and Tolerability of New Daily Oral Vitamin B12 and Intermittent Intramuscular Vitamin B12

This study was originally published by Elsevier HS Journals on March 14, 2011. The objective of the study was to compare the efficacy and safety profile of a new proprietary oral vitamin B12 formulation (oral B12) with intramuscular (IM) vitamin B12 (IM B12) in restoring normal serum B12 concentrations in patients with low cobalamin levels (<350pg/ml).

Vitamin B12 deficiency is routinely treated with parenteral dosing and less often with high-dose oral vitamin B12.

Oral vitamin B12 formulations have low bioavailability in patients with malabsorption and are considered less reliable than parenteral treatments.

Download to find out more.

Study: Comparing Efficacy and Tolerability of New Daily Oral Vitamin B12 and Intermittent Intramuscular Vitamin B12

For Free, instant access, click below.

Download Whitepaper

I have read and accept the terms and conditions and privacy policy.
We'd like to keep you informed about relevant promotions, products and services, if you would like not to receive these, check this box.
If you would like to hear from carefully selected third party companies, check this box
Follow this company to receive notifications when they update.




Thank You

Your white paper is now downloading... Click here if the download does not begin.

Go Top